2.3. Characterization of the Complex
Structural characterization of the individual reagents and reaction products was carried out by Fourier-transform infrared spectroscopy (FTIR). The FTIR spectra were registered on an FT-IR Bruker Vertex 70 Spectrophotometer by ATR technique using samples as powders. The solubility of the synthesized complex was qualitatively evaluated by the dissolution of 5 mg of complex in 1ml of several solvents (chloroform, acetone, ethanol, methanol, DMSO). The UV-VIS spectra were recorded on a Shimadzu UV-1280 spectrophotometer using diluted polymer solution approx.10 ֿ5 M) in methanol. The morphology of the polymer coatings was evaluated by SEM using Verios G4 UC Scanning Electron Microscope from Thermo Fisher Scientific (Waltham, MA, USA).
For the newly synthetized complex, the investigation regarding the biological activity was assessed by the in vitro antioxidant, antidiabetic and antibacterial activity.
Antioxidant assay
Antioxidant potential was evaluated by three different methods: iron chelation test, hydroxyl radical test and inhibition of lipoxygenase (15-LOX) activity [
13,
14,
15].
For the iron (II) chelation test, ferrozine was used, due to its ability to form complexes with ferrous iron in a quantitative manner, resulting in the production of a pink color. Nevertheless, the introduction of chelating agents results in the disturbance of complex formation, which leads to a decreasing in the intensity of coloration. The monitoring of the ferrous ion was conducted through the measurement of the formation of a pink ferrous ion-ferrozine complex at a wavelength of 562 nm. The methodology employed in this study closely resembled the approach outlined by
Burlec et al. [
16]. Using 0.2 mL of sample solution in ultrapure water, 0.74 mL of 0.1 M acetate buffer solution (pH 5.25), 0.02 mL of 2 mM ferrous sulphate solution, 0.2 M hydrochloric acid were added, and after stirring for 10-15 seconds, 0.04 mL of 5 mM ferrozine solution was slowly poured. After 10 minutes of resting in the dark, the absorbance of the solution at 562 nm was determined using a standard solution, prepared under the same conditions as the sample (the ferrous sulphate solution was replaced by ultrapure distilled water). In parallel, the control solution and its blank were prepared, the control containing 0.2 mL of ultrapure water, 0.74 mL of 0.1 M acetate buffer solution (pH 5.25), 0.02 mL of 2 mM ferrous sulphate solution in 0.2 M hydrochloric acid, and after stirring for 10-15 seconds, 0.04 mL of 5 mM ferrozine solution [
16,
17].
The chelating capacity of the ferrous ion was calculated according to the formula:
where:
Ac - absorbance of the control solution,
Ap - absorbance of the sample solution
The hydroxyl radical is generated through the reaction between the ferrous ion and hydrogen peroxide. This hydroxyl radical then reacts with salicylic acid, resulting in the formation of a pink-purple compound that exhibits its highest absorbance at a wavelength of 562 nm [
5,
13]. The absorbance of the control sample was measured at a wavelength of 562 nm, relative to the control sample where the ferrous sulfate solution was substituted with distilled water. In this experiment, a volume of 0.225 mL of sample solution dissolved in dimethyl sulfoxide (DMSO) was combined with 0.750 mL of a 1.5 mM iron (II) sulfate solution, 0.9 mL of a 20 mM sodium salicylate solution, and 0.525 mL of a 6 mM hydrogen peroxide solution. The mixture was incubated for 30 minutes at 37℃. Subsequently, the mixture was allowed to cool down to the ambient room temperature. The absorbance of the sample (referred to as the control) was then measured at a wavelength of 562 nm. This measurement was compared to the control sample, where the ferrous sulfate solution was substituted with bi-distilled water. The positive control underwent the same processing conditions as the samples, with the exception that dimethyl sulfoxide (DMSO) was utilized in place of the sample solution [
12,
18,
19].
The determination of lipoxygenase inhibition involved assessing the activity of 15-sLOX by monitoring spectrophotometrically the formation of reaction products at a wavelength of 234 nm. The experimental procedures involved conducting all reactions with a final volume of 2 ml and stirring the mixture using a magnetic bar at ambient temperature. The experimental setup involved the utilization of a reaction medium comprising a HEPES buffer with a concentration of 0.1 M and a pH value of 7.4. The experimental procedure involved the addition of the inhibitor (complex) in methanol to the cuvette containing the substrate buffer, followed by the subsequent addition of the enzyme. [
1,
9].
0.05 mL of 15-lipoxygenase solution in borate buffer pH 9 was treated with 0.05 mL of analyte solution diluted in DMSO and the mixture was left to rest for 10 minutes at room temperature, after which 2 mL of 0.16 mM linoleic acid solution in 0.1M borate buffer pH 9 was added. The absorbance of the solution was recorded at 234 nm, in the range of 0-120 seconds. In parallel, the positive control was processed in which the solution to be analyzed was replaced by DMSO. Gallic acid was used as a reference substance, and solutions of gallic acid in DMSO were processed under the same conditions as the methanolic extract.
All determinations were performed in triplicate, the results being expressed as the mean of three determinations ± standard deviation.
The lipoxygenase inhibition capacity was calculated according to the formula:
where:
AEFI - represents the difference between the absorbance of the enzyme solution without inhibitor at 90 seconds and the absorbance of the same solution at 30 seconds;
AECI - represents the difference between the absorbance of the inhibitor-treated enzyme solution (sample) at 90 seconds and the absorbance of the same solution at 30 seconds.
Antidiabetic activity
Antidiabetic assay was performed by determining the alpha-amylase and alpha-glucosidase assays.
Alpha-amylase catalyzes the hydrolysis of starch with the release of glucose which reacts with dinitrosalicylic acid and forms a yellow-orange colored compound with maximum absorbance at 540 nm. In the presence of enzyme inhibitors, enzyme activity is blocked or reduced with a reduction in the absorbance of the solution at 540 nm. A 0.4 mL sample solution dissolved in DMSO was combined with 0.08 mL of an enzyme solution with a concentration of 2 IU/mL, 0.2 mL of a starch solution with a concentration of 0.5%, and 0.16 mL of a phosphate buffer with a concentration of 20 mM and a pH of 6.7. The resulting mixture was incubated at 37°C 10 minutes. Following a time interval of 10 minutes, a volume of 0.32 mL of dinitrosalicylic reagent solution was introduced into the reaction mixture, which was subsequently subjected to a temperature of 100℃ for 15 minutes. The solution underwent a cooling process, following which the absorbance of the sample was measured relative to the sample control that lacked the addition of any enzyme. The positive control was acquired using the same procedure, employing DMSO instead of the complex [
9,
20,
21,
22].
The enzyme inhibition capacity was calculated according to the formula:
where:
Ac - represents the absorbance of the control solution,
Ap - represents the absorbance of the sample solution.
Alpha-glucosidase catalyzes the hydrolysis of pNFG to p-nitrophenylphosphate, a yellow compound with maximum absorbance at 405 nm. In the presence of inhibitors, the enzyme activity decreases or is blocked with the reduction of absorbance of the solution at 405 nm [
23,
24].
We prepared the solutions following this protocol: 0.08 mL of 2 IU/mL enzyme solution, 0.2 mL of 0.5% starch and 0.16 mL of 20 mM phosphate buffer solution pH 6.7 were added to 0.4 mL of sample solution in dimethyl sulfoxide and the solution was maintained for 10 minutes at 37oC. After 10 minutes, 0.32 m dinitrosalicylic reagent solution was added, and the reaction was maintained for 15 minutes at 100℃. The solution was cooled, and the absorbance of the sample was read against the sample control in which no enzyme was added. The positive control was processed under the same conditions as the samples, but dimethyl sulfoxide was used instead of the sample solution.
The enzyme inhibition capacity was calculated according to the formula:
where:
Ac - absorbance of the control solution,
Ap - absorbance banks of the sample solution
The IC50 value, expressed in µg sample/mL final solution, was calculated for samples exhibiting an enzyme inhibition capacity exceeding 50%. The IC50 value was determined by considering the concentration of the antioxidant agent solution that corresponds to an activity of 50%, using linear interpolation based on the first lower and higher values of 50%. The experiments were conducted in triplicate, and the outcomes were reported as t the mean of three determinations ± standard deviation. In order to establish accurate correlations and determine statistical significance, a t-student analysis was conducted.
Antibacterial activity
The antibacterial activity was determined using the disk diffusion test against Staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, Klebsiella and Candida albicans ATCC 90028.
We tested the antimicrobial activity of the synthesized complexes both by applying qualitative methods, through the diffusometric method, and by quantitative methods, applying the method of microdilutions in broth (CLSI 2023, CLSI 2009). For the tests, the microorganisms were incubated in inclined tubes, with nutrient agar for bacteria, respectively Sabouraud agar for fungi.
A standardized inoculum of 5x104UFC/ml of the test bacterial strain was seeded in a discontinuous concentration gradient of the test products, made in Mueller-Hinton broth/Liquid Sabouraud medium. After overnight incubation at 37℃, we determined the minimum inhibitory concentration, as the lowest antibiotic dilution that inhibited visible bacterial growth.
The limits of the concentrations tested for each sample were between 0.01-10 mg/mL. CMB/CMF values were determined by transferring 0.1 µl of each well that showed complete inhibition of visible growth onto the surface of a solid medium plate. The subcultures were incubated for 24 hours at 37°C (for bacteria) and 30°C (for fungi). The CMB/CMF value was considered as the lowest compound concentration that kills 99.9% of the tested microorganisms.
The inoculum was obtained from the 24-hour culture of each test microorganism and 48 hours for
Candida spp. The suspension in isotonic saline solution (0.9% NaCl) was adjusted to the density of the 0.5 McFarland standard, with the final density of ~108 Colony Forming Units/ml (CFU/ml) for bacteria, respectively ~107 CFU/ml for
Candida (CLSI, 2023). Mueller-Hinton agar medium was inoculated with this suspension, melted and brought to a temperature of 44-45°C. The inoculated medium was distributed in Petri plates with a diameter of 9 cm, in a volume of 10 ml/plate. For
Candida spp. we used Sabouraud agar medium [
10,
25,
26,
38].
In stainless steel cylinders, with a diameter of 7 mm, placed on the surface of the medium inoculated with each test microorganism, we deposited with a micropipette a volume of 100 µl of each sample, after which the plates were incubated at 37℃ for bacteria, respectively 30℃ for
Candida spp. After 24-48 hours of incubation, the antimicrobial activity was evaluated by measuring the diameter of the zone of inhibition of the growth of the test microorganisms compared to the control (reference standard) - disks impregnated with precise concentrations of antibiotics: ciprofloxacin 10 µg (Oxoid) and nystatin 100 µg (HiMedia Laboratory) [
27,
36,
37].
Each sample was tested 3 times, and the final result represents the average of the values of three diameters of the zones of inhibition of the growth of test microorganisms.